N-(2-Methoxyethyl)-3-nitropyridine-2-amine, 95.0%, 1g

4,4'-Dimethoxybenzhydrylamine, 97.0%, 5g

Nanodiamond (particle size : <10nm) (Amine-modified)1g

2-(allylthio)propanoic acid, 95.0%, 1g

7-Bromooxindole, 95.0%, 5g

3-(4-Ethylphenyl)butanoic acid, 95+%, 5g

(2R,6S)-6-(benzyloxymethyl)-4-(tert-butoxycarbonyl)morpholine-2-carboxylic acid, 98%, 250mg

4-Chloro-2-methoxyphenylboronic acid, 95.0%, 10g

Methyl 6-chloro-5-nitronicotinate, 98.0%, 10g

Ethyl 5-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-carboxylate, 98%, 100mg

Midecamycin, >98.0%, 250mg

2-Methyl-3-(piperidin-4-yloxy)pyridine, 250mg

Plan phase PLPHi S40x/0.65 infinity corrected IOS objective. Working distance 0.66 mm